Structure-activity relationships of fatty acid amide ligands in activating and desensitizing G protein-coupled receptor 119

被引:8
作者
Kumar, Pritesh [1 ]
Kumar, Akhilesh [1 ]
Song, Zhao-Hui [1 ]
机构
[1] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA
基金
美国国家卫生研究院;
关键词
G protein-coupled receptor 119; Fatty acid amides; Structure-activity relationship; GPR119; AGONISTS; GLYCEMIC CONTROL; G-PROTEIN-COUPLED-RECEPTOR-119; OLEOYLETHANOLAMIDE; DISCOVERY; BIOLOGY; CELL;
D O I
10.1016/j.ejphar.2013.10.044
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of the current study was to apply a high throughput assay to investigate the structure-activity relationships of fatty acid amides for activating and desensitizing G protein-coupled receptor 119, a promising therapeutic target for both type 2 diabetes and obesity. A cell-based, homogenous time resolved fluorescence (HTRF) method for measuring G protein-coupled receptor 119-mediated increase of cyclic adenosine monophosphate (cAMP) levels was validated and applied in this study. Using novel fatty acid amides and detailed potency and efficacy analyses, we have demonstrated that degree of saturation in acyl chain and charged head groups of fatty acid amides have profound effects on the ability of these compounds to activate G protein-coupled receptor 119. In addition, we have demonstrated for the first time that pretreatments with G protein-coupled receptor 119 agonists desensitize the receptor and the degrees of desensitization caused by fatty acid amides correlate well with their structure-activity relationships in activating the receptor. (C) 2013 Elsevier B.V. All rights reserved
引用
收藏
页码:465 / 472
页数:8
相关论文
共 21 条
  • [1] Biology of incretins: GLP-1 and GIP
    Baggio, Laurie L.
    Drucker, Daniel J.
    [J]. GASTROENTEROLOGY, 2007, 132 (06) : 2131 - 2157
  • [2] Novel cannabinoid receptors
    Brown, A. J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (05) : 567 - 575
  • [3] Chu Z., 2007, ENDOCRINOLOGY
  • [4] A role for β-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release
    Chu, Zhi-Liang
    Jones, Robert M.
    He, Hongmei
    Carroll, Chris
    Gutierrez, Veronica
    Lucman, Annette
    Moloney, Molly
    Gao, Hui
    Mondala, Helen
    Bagnol, Didier
    Unett, David
    Liang, Yin
    Demarest, Keith
    Semple, Graeme
    Behan, Dominic P.
    Leonard, James
    [J]. ENDOCRINOLOGY, 2007, 148 (06) : 2601 - 2609
  • [5] N-Oleoyldopamine Enhances Glucose Homeostasis through the Activation of GPR119
    Chu, Zhi-Liang
    Carroll, Chris
    Chen, Ruoping
    Alfonso, Jean
    Gutierrez, Veronica
    He, Hongmei
    Lucman, Annette
    Xing, Charles
    Sebring, Kristen
    Zhou, Jinyao
    Wagner, Brandee
    Unett, David
    Jones, Robert M.
    Behan, Dominic P.
    Leonard, James
    [J]. MOLECULAR ENDOCRINOLOGY, 2010, 24 (01) : 161 - 170
  • [6] THE SIGNIFICANCE OF GPR119 AGONISTS AS A FUTURE TREATMENT FOR TYPE 2 DIABETES
    Dhayal, Shalinee
    Morgan, Noel G.
    [J]. DRUG NEWS & PERSPECTIVES, 2010, 23 (07) : 418 - 424
  • [7] GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms
    Flock, Grace
    Holland, Dianne
    Seino, Yutaka
    Drucker, Daniel J.
    [J]. ENDOCRINOLOGY, 2011, 152 (02) : 374 - 383
  • [8] Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives
    Fredriksson, R
    Höglund, PJ
    Gloriam, DEI
    Lagerström, MC
    Schiöth, HB
    [J]. FEBS LETTERS, 2003, 554 (03): : 381 - 388
  • [9] Receptors for acylethanolamides-GPR55 and GPR119
    Godlewski, Grzegorz
    Offertaler, Laszlo
    Wagner, Jens A.
    Kunos, George
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2009, 89 (3-4) : 105 - 111
  • [10] GPR119 agonists for the treatment of type 2 diabetes
    Jones, Robert M.
    Leonard, James N.
    Buzard, Daniel J.
    Lehmann, Juerg
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (10) : 1339 - 1359